These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 31247995

  • 1. From Discovery of Snake Venom Disintegrins to A Safer Therapeutic Antithrombotic Agent.
    Kuo YJ, Chung CH, Huang TF.
    Toxins (Basel); 2019 Jun 26; 11(7):. PubMed ID: 31247995
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Snake venom disintegrins: classification and therapeutic potential].
    Kallech-Ziri O, Luis J, El Ayeb M, Marrakchi N.
    Arch Inst Pasteur Tunis; 2007 Jun 26; 84(1-4):29-37. PubMed ID: 19388581
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Snake venom metalloproteinase containing a disintegrin-like domain, its structure-activity relationships at interacting with integrins.
    Lu X, Lu D, Scully MF, Kakkar VV.
    Curr Med Chem Cardiovasc Hematol Agents; 2005 Jul 26; 3(3):249-60. PubMed ID: 15974889
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Purification and characterization of a new RGD/KGD-containing dimeric disintegrin, piscivostatin, from the venom of Agkistrodon piscivorus piscivorus: the unique effect of piscivostatin on platelet aggregation.
    Okuda D, Morita T.
    J Biochem; 2001 Sep 26; 130(3):407-15. PubMed ID: 11530017
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Functional characteristic of snake venom disintegrins: potential therapeutic implication.
    Marcinkiewicz C.
    Curr Pharm Des; 2005 Sep 26; 11(7):815-27. PubMed ID: 15777236
    [Abstract] [Full Text] [Related]

  • 11. FcgammaRII mediates platelet aggregation caused by disintegrins and GPIIb/IIIa monoclonal antibody, AP2.
    Huang TF, Chang CH, Ho PL, Chung CH.
    Exp Hematol; 2008 Dec 26; 36(12):1704-13. PubMed ID: 18809237
    [Abstract] [Full Text] [Related]

  • 12. Contortrostatin, a snake venom disintegrin with anti-angiogenic and anti-tumor activity.
    Swenson S, Costa F, Ernst W, Fujii G, Markland FS.
    Pathophysiol Haemost Thromb; 2005 Dec 26; 34(4-5):169-76. PubMed ID: 16707922
    [Abstract] [Full Text] [Related]

  • 13. The integrin alpha IIb beta 3 contains distinct and interacting binding sites for snake-venom RGD (Arg-Gly-Asp) proteins. Evidence that the receptor-binding characteristics of snake-venom RGD proteins are related to the amino acid environment flanking the sequence RGD.
    Rahman S, Lu X, Kakkar VV, Authi KS.
    Biochem J; 1995 Nov 15; 312 ( Pt 1)(Pt 1):223-32. PubMed ID: 7492316
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Anti-angiogenesis and RGD-containing snake venom disintegrins.
    Swenson S, Ramu S, Markland FS.
    Curr Pharm Des; 2007 Nov 15; 13(28):2860-71. PubMed ID: 17979731
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Thrombolytic effects of the snake venom disintegrin saxatilin determined by novel assessment methods: a FeCl3-induced thrombosis model in mice.
    Kwon I, Hong SY, Kim YD, Nam HS, Kang S, Yang SH, Heo JH.
    PLoS One; 2013 Nov 15; 8(11):e81165. PubMed ID: 24260554
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.